Bookmark and Share

Intellectual Property Issues of Biomedical Outsourcing in China

Issued: March 01 2013

China has become one of the most important outsourcing destination countries, acquiring a considerable market share of the global outsourcing market. Mia Qu provides an overview of the intellectual property issues as related to biomedical outsourcing in the Chinese context.

 

Related Articles

  • Before Sue-rise
    Much can be done by both law firms and companies to resolve disputes before hitting litigation. Johnny Chan reveals the secrets.
  • MOFCOM Issues New Guidelines on Divestit...
    When MOFCOM approved Pfizer’s acquisition of Wyeth last year, the Chinese anti-trust authority applied business divestiture as a struct...
  • Study: 70% of All Counterfeits from Chin...
    A recent United Nations study says that 70% of all counterfeits seized globally came from China. Lily Zhang explores the history of cou...
  • Meeting the Experts
    In December, more than 1,600 IP buyers and sellers, R&D professionals, financial intermediaries and lawyers came together in Hong Kong ...
  • Asia Steps Up in Trademark Enforcement
    While trademark laws vary from country to country, the aim of stronger enforcement is the same globally. Lily Zhang talks to lawyers fr...
  • Proceedings After Receiving Decision of ...
    Recent changes to Japan’s Patent Law have created new opportunities for applicants to seek a patent following a Decision of Rejection. ...
 

Law Firms